Steroid minimization immunosuppression protocol using basiliximab in adult living donor liver transplantation for hepatitis C virus-related cirrhosis

Aim Recent randomized trials have failed to prove the benefit of steroid‐free immunosuppression in liver transplantation for hepatitis C virus (HCV)‐related cirrhosis. Furthermore, there is a lack of data on the use of basiliximab in living donor liver transplantation (LDLT). This pilot study evalua...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hepatology research 2015-12, Vol.45 (12), p.1178-1184
Hauptverfasser:	Hibi, Taizo, Shinoda, Masahiro, Itano, Osamu, Obara, Hideaki, Kitago, Minoru, Abe, Yuta, Yagi, Hiroshi, Tanaka, Masayuki, Hoshino, Ken, Fujino, Akihiro, Kuroda, Tatsuo, Kawachi, Shigeyuki, Tanabe, Minoru, Shimazu, Motohide, Kitagawa, Yuko
Format:	Artikel
Sprache:	eng
Schlagworte:	basiliximab hepatitis C virus immunosuppression liver transplantation living donors steroids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!